Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-06

Clinical Trial Update: Safety and Efficacy of Stem Cells for Diabetic Foot Ulcer [Phase 1, Phase 2]

View source ↗

Summary

A trial update on the safety and efficacy of stem cells for diabetic foot ulcers in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stem cells (mesenchymal stem cells)

Snippet

Sponsor: Supergenics Life Science Sdn. Bhd. | Conditions: Diabetic Foot Ulcer | Phase 1, Phase 2 | Status: UNKNOWN